4-aminopyridine is not just a symptomatic therapy, it has a neuroprotective effect – Yes

Eva M.M. Strijbis*, Jenny A. Nij Bijvank, Joep Killestein

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1309-1310
Number of pages2
JournalMultiple Sclerosis Journal
Issue number11
Publication statusPublished - 1 Oct 2020

Cite this